GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intravenous Infusions Ltd (XGHA:IIL) » Definitions » Total Payout Yield %

Intravenous Infusions (XGHA:IIL) Total Payout Yield % : 0.00 (As of Jun. 19, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Intravenous Infusions Total Payout Yield %?

Total Payout Yield % is the percent a company has paid to its shareholders through net repurchases of shares and dividends based on its Market Cap. It is a measure of shareholder return.

Intravenous Infusions's current Total Payout Yield % is 0.00%.


Intravenous Infusions Total Payout Yield % Historical Data

The historical data trend for Intravenous Infusions's Total Payout Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intravenous Infusions Total Payout Yield % Chart

Intravenous Infusions Annual Data
Trend
Total Payout Yield %

Intravenous Infusions Semi-Annual Data
Total Payout Yield %

Competitive Comparison of Intravenous Infusions's Total Payout Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Intravenous Infusions's Total Payout Yield %, along with its competitors' market caps and Total Payout Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intravenous Infusions's Total Payout Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Intravenous Infusions's Total Payout Yield % distribution charts can be found below:

* The bar in red indicates where Intravenous Infusions's Total Payout Yield % falls into.



Intravenous Infusions Total Payout Yield % Calculation

Total Payout Yield % is a measure of shareholder return.

Intravenous Infusions's Total Payout Yield % for the fiscal year that ended in . 20 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Market Cap
=- ( + + ) /
=N/A%

Intravenous Infusions's annualized Total Payout Yield % for the quarter that ended in . 20 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) * Annualized Factor / Market Cap
=- ( + + ) * 1 /
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Intravenous Infusions Total Payout Yield % Explanation

Similar to Dividend Yield, Total Payout Yield % is a measurement of shareholder return. Dividends is not the only way that companies are able to distribute their excess cash back to the shareholders. The other way to distribute the cash is a stock repurchase. The stock repurchase buys back the company's own shares from the marketplace. This results in a reduced number of oustanding shares, making each share worth a greater percentage of the corporation.


Intravenous Infusions Total Payout Yield % Related Terms

Thank you for viewing the detailed overview of Intravenous Infusions's Total Payout Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Intravenous Infusions (XGHA:IIL) Business Description

Traded in Other Exchanges
N/A
Address
Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA
Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.